Algorithms for early detection of prostate cancer. Current state of the “art”
✍ Scribed by Munekado Kojima; Richard J. Babaian
- Publisher
- John Wiley and Sons
- Year
- 1995
- Tongue
- English
- Weight
- 890 KB
- Volume
- 75
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
✦ Synopsis
The common feature among algorithms currently available is that a low level of serum prostate specific antigen (PSA) (4 ng/ml or lower) associated with a normal digital rectal examination (DRE) indicates the need for neither a transrectal ultrasound (TRUS) examination nor biopsy, and a high level of serum PSA (higher than 10 ng/ml) indicates the need for a biopsy, regardless of DRE and TRUS findings. The unresolved problem is how to deal with men whose serum PSA levels are intermediately elevated (4.1-10 ng/ml). Whether PSA density, an age-adjusted reference range for PSA, or an age-adjusted reference range for PSA complement the PSA value alone has not been determined, and neither has the role of PSA velocity, which may hold more promise. This paper outlines the authors' recommendation for the early detection of prostate cancer and focuses on the obtainment of a baseline PSA level. Cancer
📜 SIMILAR VOLUMES
## Abstract The natural history of prostate cancer is remarkably heterogeneous and, at this time, not completely understood. The widespread adoption and application of prostate‐specific antigen (PSA) screening has led to a dramatic shift toward the diagnosis of low‐volume, nonpalpable, early‐stage
## BACKGROUND. The American Cancer Society National Prostate Cancer Detection Proj-(James H. Gilbaugh, Jr., M.D.); Urology Clinic ect (ACS-NPCDP) was established in 1987. The experience of the ACS-NPCDP demonof Yakima, Yakima, Washington (Mark Uhlman, strates the yield and impact of periodic exami
## Abstract The aim of our study was to estimate uptake of prostate‐specific antigen (PSA) testing in an entire country, including time trends and geographical differences. Data from the Swedish Cancer Register on prostate cancer incidence between 1980 and 2007 and published data from the Gothenbur